Association between left ventricular end-diastolic pressure and coronary artery disease as well as its extent and

Lai-Jing Du1, Ping-Shuan Dong1, Jing-Jing Jia1

  • 1Department of Cardiology, The First Affiliated Hospital of Henan Science and Technology University Luoyang 471003, China.

Insights

Elevated left ventricular end-diastolic pressure (LVEDP) is linked to coronary artery disease (CAD). Higher LVEDP indicates more severe CAD, offering clinical value for both CAD and non-CAD patients.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Diagnostic Medicine

Background:

  • Myocardial ischemia is associated with elevated left ventricular end-diastolic pressure (LVEDP).
  • Left ventricular end-diastolic pressure (LVEDP) is a key indicator of cardiac function.
  • Coronary artery disease (CAD) significantly impacts cardiac hemodynamics.

Purpose of the Study:

  • To investigate the correlation between LVEDP and the presence, extent, and severity of coronary artery disease (CAD).
  • To assess the clinical utility of LVEDP measurement in patients undergoing coronary angiography (CAG).

Main Methods:

  • A retrospective analysis of 912 patients who underwent both left cardiac catheterization and coronary angiography (CAG).
  • Coronary artery disease (CAD) was assessed by CAG, and its extent/severity by the number of affected vessels and Gensini score.
  • Statistical analysis, including correlation and linear regression, was used to evaluate LVEDP relationships.

Main Results:

  • Patients with CAD had significantly higher LVEDP compared to those without CAD (10.9±5.46 mmHg vs 9.58±5.78 mmHg, P<0.001).
  • LVEDP showed a significant independent correlation with the presence of CAD (OR = 0.11 per 5 mmHg increase, P = 0.02).
  • LVEDP increased with the number of diseased vessels and was significantly associated with the Gensini score (standardized β = 0.034, P = 0.001). In non-CAD patients, LVEDP correlated only with age.

Conclusions:

  • Elevated LVEDP is significantly associated with the presence, extent, and severity of coronary artery disease (CAD).
  • LVEDP measurement provides incremental clinical value for assessing cardiovascular risk in both CAD and non-CAD patients.
  • In patients without CAD, LVEDP was found to correlate solely with age.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
948
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
552
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
839
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K